Evidence map›Paper›PMID 33238111›Full record

ArticleCell reports2020

Shigella flexneri Disruption of Cellular Tension Promotes Intercellular Spread.

Jeffrey K Duncan-Lowey, Alexandra L Wiscovitch, Thomas E Wood, Marcia B Goldberg, Brian C Russo

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. ThemSphere · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. ThemBio · 2025
    Article
  8. Article
  9. A RecombinantInternational journal of molecular sciences · 2024
    Article
  10. Article
  11. Review
  12. PathogenicJournal of bacteriology · 2024
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. The T3SS ofMicroorganisms · 2020
    Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Jeffrey K Duncan-LoweyCenter for Bacterial Pathogenesis, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
Alexandra L WiscovitchResearch Scholar Initiative, The Graduate School of Arts and Sciences, Harvard University, Cambridge, MA 02138, USA.
Thomas E WoodCenter for Bacterial Pathogenesis, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.
Marcia B GoldbergCenter for Bacterial Pathogenesis, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA. Electronic address: marcia.goldberg@mgh.harvard.edu.
Brian C RussoCenter for Bacterial Pathogenesis, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA. Electronic address: brian.russo@cuanschutz.edu.
Boston VA Research Institute · USMassachusetts General Hospital · USThe Graduate Center, CUNY · US

Funding

INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
Molecular signaling in Shigella disseminationR01AI081724 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 2010 to 2026
$7.1M
Diversity in Biomedical Sciences Via Personalized Research and Education Programs for Post-BaccalaureatesR25GM109436 · NIGMS · HARVARD UNIVERSITY · PI D'SOUZA, VICTORIA MANUEL, VELEZ-RUIZ, GISSELLE A · 2016 to 2024
$2.5M
The Type 3 Secretion System Translocon Pore in Bacterial PathogenesisK22AI137296 · NIAID · UNIVERSITY OF COLORADO DENVER · PI RUSSO, BRIAN · 2020 to 2021
$268k
Molecular signaling in Shigella disseminationR56AI081724 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI GOLDBERG, MARCIA B · 2009 to 2009
$189k
Role of host factors during effector translocation by type III secretionF32AI114162 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RUSSO, BRIAN · 2016 to 2017
$84k
NIAID NIH HHS F32 AI114162NIAID NIH HHS K22 AI137296NIAID NIH HHS R01 AI081724NIAID NIH HHS R56 AI081724NIAID NIH HHS T32 AI007061NIGMS NIH HHS R25 GM109436
6 · The paper itself

Abstract

During infection, some bacterial pathogens invade the eukaryotic cytosol and spread between cells of an epithelial monolayer. Intercellular spread occurs when these pathogens push against the plasma membrane, forming protrusions that are engulfed by adjacent cells. Here, we show that IpaC, a Shigella flexneri type 3 secretion system protein, binds the host cell-adhesion protein β-catenin and facilitates efficient protrusion formation. S. flexneri producing a point mutant of IpaC that cannot interact with β-catenin is defective in protrusion formation and spread. Spread is restored by chemical reduction of intercellular tension or genetic depletion of β-catenin, and the magnitude of the protrusion defect correlates with membrane tension, indicating that IpaC reduces membrane tension, which facilitates protrusion formation. IpaC stabilizes adherens junctions and does not alter β-catenin localization at the membrane. Thus, Shigella, like other bacterial pathogens, reduces intercellular tension to efficiently spread between cells.

Indexed as

Antigens, BacterialCell MembraneShigella flexneriAntigens, Bacterialcell-to-cell spreadintercellular spreadintracellular pathogensIpaCplasma membraneShigella flexneritype 3 secretion systemβ-catenin

Identifiers

PMID33238111
PMCPMC7792532
OpenAlexW3110273395

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.